These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 10452346

  • 1. Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.
    Sartori TM, Maurizio PG, Sara P, Ugolino L, Annalisa A, Panagiotis T, Massimo F, Antonio G.
    J Heart Lung Transplant; 1999 Jul; 18(7):693-700. PubMed ID: 10452346
    [Abstract] [Full Text] [Related]

  • 2. Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation.
    Patrassi GM, Sartori MT, Livi U, Casonato A, Danesin C, Vettore S, Girolami A.
    Transplantation; 1997 Dec 15; 64(11):1610-4. PubMed ID: 9415568
    [Abstract] [Full Text] [Related]

  • 3. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
    Sartori MT, Rigotti P, Marchini F, Spiezia L, Baldan N, Furian L, Varvarikis C, Girolami A.
    Transplantation; 2003 Apr 15; 75(7):994-8. PubMed ID: 12698086
    [Abstract] [Full Text] [Related]

  • 4. Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients.
    Sartori MT, Patrassi GM, Rigotti P, Marchini F, Fioretti M, Spiezia L, Girolami A.
    Transplantation; 2000 May 27; 69(10):2116-21. PubMed ID: 10852608
    [Abstract] [Full Text] [Related]

  • 5. Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment.
    Patrassi GM, Sartori MT, Rigotti P, Di Landro D, Theodoridis P, Fioretti M, Capalbo M, Saggiorato G, Boeri G, Girolami A.
    Transplantation; 1995 May 27; 59(10):1416-20. PubMed ID: 7770928
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.
    van den Dorpel MA, Veld AJ, Levi M, ten Cate JW, Weimar W.
    Arterioscler Thromb Vasc Biol; 1999 Jun 27; 19(6):1555-8. PubMed ID: 10364089
    [Abstract] [Full Text] [Related]

  • 7. The effect of chronic allograft rejection on plasma regulators of fibrinolysis.
    Perkowska A, Elhasade A, Durlik M, Placha G, Gałazka Z, Lao M, Gaciong Z.
    Ann Transplant; 2002 Jun 27; 7(1):44-51. PubMed ID: 12221903
    [Abstract] [Full Text] [Related]

  • 8. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients.
    Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M.
    Transplantation; 1996 Sep 27; 62(6):828-30. PubMed ID: 8824484
    [Abstract] [Full Text] [Related]

  • 9. Some aspects of hemostasis in kidney transplant recipients maintained on cyclosporine, azathioprine, and prednisone in comparison to patients treated with cyclosporine and prednisone.
    Malyszko J, Malyszko JS, Hryszko T, Mysliwiec M.
    Transplant Proc; 2003 Dec 27; 35(8):2940-2. PubMed ID: 14697944
    [Abstract] [Full Text] [Related]

  • 10. The effect of cyclosporine on regulators of fibrinolysis in plasma from renal allograft recipients.
    Elhasade AS, Perkowska A, Paczek L, Rowiński W, Soluch L, Szmidt J, Gałazka Z, Gaciong Z.
    Ann Transplant; 1998 Dec 27; 3(1):13-8. PubMed ID: 9869892
    [Abstract] [Full Text] [Related]

  • 11. Blood coagulation, fibrinolytic and inhibitory profiles in renal transplant recipients: comparison of cyclosporine and azathioprine.
    Vaziri ND, Ismail M, Martin DC, Gonzales E.
    Int J Artif Organs; 1992 Jun 27; 15(6):365-9. PubMed ID: 1639529
    [Abstract] [Full Text] [Related]

  • 12. Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.
    Gotti E, Perico N, Perna A, Gaspari F, Cattaneo D, Caruso R, Ferrari S, Stucchi N, Marchetti G, Abbate M, Remuzzi G.
    J Am Soc Nephrol; 2003 Mar 27; 14(3):755-66. PubMed ID: 12595513
    [Abstract] [Full Text] [Related]

  • 13. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
    Nohria A, Ehtisham J, Ramahi TM.
    J Heart Lung Transplant; 1998 Sep 27; 17(9):849-53. PubMed ID: 9773855
    [Abstract] [Full Text] [Related]

  • 14. Hemostatic/fibrinolytic predictors of allograft coronary artery disease after cardiac transplantation.
    Meckel CR, Anderson TJ, Mudge GH, Mitchell RN, Yeung AC, Selwyn AP, Ganz P, Simon DI.
    Vasc Med; 1997 Nov 27; 2(4):306-12. PubMed ID: 9575604
    [Abstract] [Full Text] [Related]

  • 15. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy.
    Felkel TO, Smith AL, Reichenspurner HC, LaFleur B, Lutz JF, Kanter KR, Gravanis MB, Johnston TS.
    J Heart Lung Transplant; 2002 May 27; 21(5):530-9. PubMed ID: 11983542
    [Abstract] [Full Text] [Related]

  • 16. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec 27; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 17. Fibrinolysis in chronic renal failure, dialysis and renal transplantation.
    Opatrný K, Zemanová P, Opatrná S, Vít L.
    Ann Transplant; 2002 Dec 27; 7(1):34-43. PubMed ID: 12221902
    [Abstract] [Full Text] [Related]

  • 18. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
    Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A.
    Blood Coagul Fibrinolysis; 1992 Dec 27; 3(6):789-93. PubMed ID: 1489900
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients.
    Penson MG, Winter WE, Fricker FJ, Harker K, Kahler DA, Kubilis PS, Schowengerdt KO.
    J Heart Lung Transplant; 1999 Jul 27; 18(7):707-13. PubMed ID: 10452348
    [Abstract] [Full Text] [Related]

  • 20. Treatment with everolimus is associated with a procoagulant state.
    Baas MC, Gerdes VE, Ten Berge IJ, Heutinck KM, Florquin S, Meijers JC, Bemelman FJ.
    Thromb Res; 2013 Aug 27; 132(2):307-11. PubMed ID: 23906938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.